Authors
Latest:
Expert Opinion: We cannot continue to ignore the problem of physician mental distress"We need health systems, state medical boards and physician employment settings to commit to prioritizing physician wellbeing and provide the reassurances and resources that encourage physicians in need to seek help," writes Russell Libby, MD.
Latest:
Malpractice Consult: How likely are you to face a medical malpractice lawsuit?"Although there is a good chance that you will face allegations of medical negligence at some point in your career, it is unlikely that you will ever be found liable by a jury," writes Victoria L. Neikam, Esq.
Latest:
Future Directions for Imaging and Biopsy in Prostate CancerThe panel offers key takeaways on the evolving landscape for imaging and biopsy in prostate cancer, highlighting the role for fusion-guided biopsy in the diagnosis and management of prostate cancer.
Latest:
US Chamber of Commerce asks for delay on non-compete ruleThe request comes amid growing concerns about the rule’s implications for businesses and employees nationwide.
Latest:
Novel dual agents for advanced prostate cancerA recap of presentations from AUA 2021 highlighting next steps using novel therapies as combination approaches to treat advanced prostate cancer.
Latest:
TikTok Videos About Urogynecologic Conditions: Yale Study Shows Misinformation Gets More Engagement“It’s important to realize that a single TikTok post can reach tens of thousands of people and potentially influence health care decisions," says Leslie Rickey, MD, MPH.
Latest:
Follow-Up After Negative Bone/CT in Prostate Cancer With Molecular RecurrenceDr Raoul Concepcion leads a multidisciplinary expert panel in a discussion about the challenges of long-term follow-up of prostate cancer in patients with negative bone/CT but positive molecular indicators of recurrence.
Latest:
MRI-based screening emerging as viable alternative to PSA testing“MRI-based screening showed lower proportions of screening-positive cases, lower false positive rates, and higher PPVs [positive predictive values] than those of PSA-based screening,” noted Taek Min Kim, MD.
Latest:
Is greater patient control of their personal health records a plus for physicians?The Cures Act has teeth and consumers are becoming increasingly aware of their right to obtain their information.
Latest:
DFS end point not reached with adjuvant nivolumab for locally advanced high-risk RCCPatient subgroups that favored nivolumab vs placebo included patients with sarcomatoid features (HR, 0.42; 95% CI, 0.17-1.07), PD-L1 expression of 1% or greater (HR, 0.53; 95% CI, 0.22-1.29), and those with lower limit of normal hemoglobin at baseline (HR, 0.49; 95% CI, 0.25-1.49).
Latest:
Moffitt Study Suggests Improvements Needed for Patient-Reported Outcome Data in Genitourinary Cancer Clinical Studies“Our data showed a considerable gap in reporting patient-reported outcomes and in the quality of design and conduct of patient-reported outcomes-related trial endpoints," said Jad Chahoud, MD, MPH.
Latest:
Emulating target trials using observational evidence to inform clinical decision-making"The emulation framework lends the design and conduct of observational analyses some of the rigor required for the planning of a randomized trial. In doing so, it provides an innovative and principled approach to improve the evidence base on the comparative effectiveness of interventions," writes Boris Gershman, MD, and Aaron Fleishman, MPH.
Latest:
Ascension cyberattack’s impact felt in multiple statesSome Ascension hospitals continue to divert ambulances to other facilities for emergency treatment, but some of the system’s hospitals are accepting all patients.
Latest:
Future Landscape of Prostate Cancer and Rectal SpacersThe expert panel concludes their discussion with a look toward the future of prostate cancer treatment and the evolving role of rectal spacers.
Latest:
Can remote patient monitoring help combat the staffing shortage?"As more patients become interested in remote patient monitoring and case studies continue to show improved patient outcomes, practices must seek ways to integrate these tools into their workflows," writes Lucienne Marie Ide, MD, PhD.
Latest:
Unmet Needs and Investigational Therapies in mCSPCDr Jason Hafron concludes his discussion of mCSPC by highlighting the need to work towards a cure for the disease, and two major clinical trials investigating triplet treatment regimens.
Latest:
PARP inhibitors: Treating mCRPC from a genetic basisTreatments provide a targeted therapeutic strategy for metastatic castration-resistant prostate cancer.
Latest:
Chronic care management in the urologic oncology settingCCM programs can engage multiple providers to care for patients while reducing in-person visits.
Latest:
What you need to know about providing telehealth in 2023Jeremy D. Sherer, JD, explains everything physicians need to know about using telemedicine in their practice in 2023.
Latest:
When it comes to urology teaching or learning opportunities, just say yes"Despite the uncertain times, I am grateful to be a student in the field of medicine, where compassion is one of the traits that defines its practitioners," says PA student Steffanie Robertus.
Latest:
Biomarker Use in Patients on Active SurveillanceThe panel explores the role of biomarkers in monitoring disease progression for prostate cancer patients on active surveillance, discussing how these tests aid in detecting changes that may warrant intervention.
Latest:
Comparing Leuprolide Formulations in Advanced Prostate CancerIn the third article of the series, Melanie McGilloway, NP-C, an advanced practice provider at Genesis Urology in San Diego, discusses the various formulations of leuprolide, a gonadotropin-releasing hormone (GnRH) agonist used for treating advanced prostate cancer.
Latest:
Management of BCG-unresponsive NMIBC"An alternative off-label option for patients with BCG-unresponsive NMIBC is sequential intravesical gemcitabine and docetaxel (Gem/Doce)," write Rachel Passarelli, MD, and Vignesh T. Packiam, MD.
Latest:
Legislation improves accessibility to mental health programs for cliniciansCongress has taken actions aimed at protecting arrangements in which hospitals and other entities provide bona fide mental health improvement, behavioral health improvement, or maintenance programs to physicians and other clinicians.
Latest:
Radium-223 is associated with low rates of AEs, treatment discontinuation for bone metastatic CRPCOf note, 55% of patients received a full course (6 injections) of radium-223 injections, and 67% received 5 of the 6 injections.
Latest:
Mayo study finds dietary habits that may help prevent kidney stones"Knowing the dietary factors that are most important for preventing kidney stone recurrence can help patients and providers know what to prioritize,” said Andrew Rule, MD.
Latest:
Management of recurrent prostate cancer after focal therapyProviders must carefully consider treatment options to align with patient preference.
Latest:
Survey highlights communication gaps with kidney cancer diagnosis and care“This indicates opportunities to improve communication about diagnosis, psychosocial impacts, and clinical trials, as well as biopsies, physical exercise, and patient engagement,” wrote Rachel H. Giles, PhD, and colleagues.
Latest:
Potential Impact of PET/CT Imaging on Improving Patient CareNeal Shore, MD, FACS, and Brian Shuch, MD, provide closing thoughts on the potential of PET/CT imaging to improve patient care in kidney cancer.
